Targeting lipid metabolism for the treatment of Anaplastic Thyroid Carcinoma

par von Roemeling, Christina A., Copland, John A.
Publié dans Expert Opin Ther Targets (2015)

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

par Smallridge, Robert C, Marlow, Laura A, Copland, John A
Publié 2008

RhoB upregulation leads to either apoptosis or cytostasis through differential target selection

par Marlow, Laura A., Bok, Ilah, Smallridge, Robert C., Copland, John A.
Publié dans Endocr Relat Cancer (2015)

FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases

par Storz, Peter, Döppler, Heike, Copland, John A., Simpson, Kaylene J., Toker, Alex
Publié 2009

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer

par Kourtidis, Antonis, Yanagisawa, Masahiro, Huveldt, Deborah, Copland, John A., Anastasiadis, Panos Z.
Publié dans PLoS One (2015)

Combined alkylation and histone deacetylase inhibition with EDO-S101 has significant therapeutic activity against brain tumors in preclinical models

par Qiu, Yushi, Li, Zhimin, Copland, John A., Mehrling, Thomas, Tun, Han W.
Publié dans Oncotarget (2018)

Engineering of hetero-functional gold nanorods for the in-vivo molecular targeting of breast cancer cells

par Eghtedari, Mohammad, Liopo, Anton V., Copland, John A., Oraevsky, Alexander A., Motamedi, Massoud
Publié 2009

Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein

par Kang, Jonghoon, Lee, Myung Soog, Copland, John A., Luxon, Bruce A., Gorenstein, David G.
Publié 2008

HYPOXIA NEGATIVELY REGULATES HEPARAN SULFATASE 2 EXPRESSION IN RENAL CANCER CELL LINES

par Khurana, Ashwani, Tun, Han W, Marlow, Laura, Copland, John A, Dredge, Keith, Shridhar, Viji
Publié 2011

Ym155 Induces Oxidative Stress-Mediated DNA Damage and Cell Cycle Arrest, and Causes Programmed Cell Death in Anaplastic Thyroid Cancer Cells

par Xu, Qinqin, Mackay, Ryan P., Xiao, Adam Y., Copland, John A., Weinberger, Paul M.
Publié dans Int J Mol Sci (2021)

Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups

par Patel, Tejal A., Colon-Otero, Gerardo, Bueno Hume, Celyne, Copland, John A., Perez, Edith A.
Publié 2010

p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression

par Soto, Edwin, Yanagisawa, Masahiro, Marlow, Laura A., Copland, John A., Perez, Edith A., Anastasiadis, Panos Z.
Publié 2008

Type III Transforming Growth Factor-β (TGF-β) Receptor Mediates Apoptosis in Renal Cell Carcinoma Independent of the Canonical TGF-β Signaling Pathway

par Margulis, Vitaly, Maity, Tapati, Zhang, Xiu-Ying, Cooper, Simon J., Copland, John A., Wood, Christopher G.
Publié 2008

PRSS3/Mesotrypsin is a therapeutic target for metastatic prostate cancer

par Hockla, Alexandra, Miller, Erin, Salameh, Moh’d A., Copland, John A., Radisky, Derek C., Radisky, Evette S.
Publié 2012

Aberrant lipid metabolism as a therapeutic target in liver cancer

par Pope, Evans D., Kimbrough, Erinmarie O., Vemireddy, Lalitha Padmanabha, Surapaneni, Phani Keerthi, Copland, John A., Mody, Kabir
Publié dans Expert Opin Ther Targets (2019)

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma

par von Roemeling, Christina A, Marlow, Laura A, Kennedy, William P, Kennedy, Gregory T, Copland, John A, Menefee, Michael E
Publié 2013

A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease

par Yanagisawa, Masahiro, Huveldt, Deborah, Kreinest, Pamela, Lohse, Christine M., Cheville, John C., Parker, Alexander S., Copland, John A., Anastasiadis, Panos Z.
Publié 2008

Selective central nervous system tropism of primary central nervous system lymphoma

par Jiang, Liuyan, Marlow, Laura A, Cooper, Simon J, Roemeling, Christina V, Menke, David M, Copland, John A, Tun, Han W
Publié 2010

Expression of the type III TGF-β receptor is negatively regulated by TGF-β

par Hempel, Nadine, How, Tam, Cooper, Simon J., Green, Tyler R., Dong, Mei, Copland, John A., Wood, Christopher G., Blobe, Gerard C.
Publié 2008

RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer

par Vishnu, Prakash, Colon-Otero, Gerardo, Kennedy, Gregory T., Marlow, Laura A., Kennedy, William P., Wu, Kevin J., Santoso, Joseph T., Copland, John A.
Publié 2011